Vogelmeier, of Philipps-University of Marburg discusses pooled data showing reduced COPD exacerbations, though most effectively in former smokers.
Claus Vogelmeier, MD
Advertisement
Articles by Claus Vogelmeier, MD
Vogelmeier discusses major changes to the annual COPD report, including a broader threshold for escalating treatment after exacerbation.
Advertisement
Latest Updated Articles
Breaking Down the 2026 GOLD Report, with Claus Vogelmeier, MDNovember 14th 2025
Advertisement
Advertisement
Trending on HCPLive
1
Mepolizumab Reduces Systemic Corticosteroid Exposure in Eosinophilic COPD
2
Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD
3
Tezepelumab Meets Co-Primary End Points in Phase 3 CROSSING Trial in EoE
4
Reaching Comprehensive Disease Control in UC, With Stefan Schreiber, MD
5